Science & Space
United States · Direct U.S. connection
Mushroom Causing Tiny Human Hallucinations Identified
Scientists have identified *Lanmaoa asiatica*, a mushroom species, as the cause of Lilliputian hallucinations, which are visions of numerous tiny humans, with research published on June 5, 2026.
Share this article
THE PRIMARY BRIEF
- 01 · The primary finding
Scientists have identified *Lanmaoa asiatica* as the mushroom causing Lilliputian hallucinations, a phenomenon where people see tiny humans, and found it contains an unknown hallucinogenic compound distinct from psilocybin or ibotenic acid.
- 02 · The primary evidence
Research by Colin Domnauer and Bryn Dentinger, published in *Mycologia* on June 5, 2026, details DNA sequencing and chemical analyses confirming *L. asiatica* in China and the Philippines, and the absence of known psychoactive substances.
- 03 · Why it matters
This discovery points to a novel hallucinogenic substance, potentially offering new avenues for understanding neurological function, visual perception, and therapeutic applications for brain diseases.
Scientists have identified Lanmaoa asiatica, a mushroom species, as the cause of Lilliputian hallucinations, a phenomenon where individuals perceive numerous tiny humans. Research published on June 5, 2026, indicates that this mushroom lacks known psychoactive compounds like psilocybin and ibotenic acid, suggesting an unidentified hallucinogenic substance is at play.
This discovery, led by researchers at the University of Utah, reveals a novel hallucinogenic compound unrelated to known psychoactive substances. It potentially opens new avenues for understanding neurological function and visual perception. The identification of this unique chemical could offer insights into neurological diseases and brain function.
Mushroom Identified
Doctoral student Colin Domnauer and mycologist Bryn Dentinger, both affiliated with the University of Utah and the Natural History Museum of Utah, co-authored the findings in the journal Mycologia. Their analyses consistently found no genetic pathways or chemical traces of known psychoactive compounds in L. asiatica, including psilocybin and ibotenic acid. The hallucinations are described as seeing dozens or hundreds of tiny, colorful human-like figures, such as whimsical fairies or elves, that interact with the real environment. The effects typically have a delayed onset of 12 to 24 hours after consumption and can last from one day to several weeks. While generally not fatal, consumption can cause gastrointestinal symptoms and, occasionally, delirium. Animal studies conducted by Domnauer’s lab showed that mice administered Lanmaoa asiatica chemical extracts exhibited pronounced hyperactivity followed by a sustained period of hypoactivity, confirming a distinct bioactive effect.
Historical Reports
The phenomenon of Lilliputian hallucinations has historical roots, with ancient records from the 3rd century CE in a Daoist text referencing a “flesh spirit mushroom” that allowed one to “see a little person”. Western researchers first documented reports of wild mushrooms causing visions of tiny people, termed “mushroom madness,” in Papua New Guinea in 1934. In the 1960s, Gordon Wasson and Roger Heim investigated these claims, sending specimens to Swiss chemist Albert Hofmann, but no active compounds were identified at the time. Interest resurfaced in the 1990s with similar reports from Yunnan, Southwest China, where locals experienced these visions after consuming wild bolete mushrooms known as “Jian shou qing”.
Global Reach Confirmed
Domnauer’s fieldwork involved collecting samples in Yunnan in 2023 and in the Northern Cordillera region of the Philippines in 2024. In the Philippines, he found a wild edible mushroom locally called “Sedesdem” that caused similar experiences. DNA sequencing confirmed that both “Jian shou qing” in China and “Sedesdem” in the Philippines were Lanmaoa asiatica, a discovery that expanded the known geographical range of the species. Domnauer recounted an experience in a Chinese hot-pot restaurant where a timer was set, with a warning not to eat the mushroom until it elapsed, “or you might start seeing little people”.
The Search for the Compound
Domnauer stated in an April 8, 2026, interview, “I think one of the most exciting parts of this project is discovering a new therapeutic potential”. The discovery of this novel hallucinogenic compound could offer insights into neurological diseases, visual perception, and brain function.
What We Could Not Confirm
The exact psychoactive compound responsible for the Lilliputian hallucinations has not yet been isolated or identified. Definitive genetic corroboration for mushrooms causing similar hallucinations in Papua New Guinea is pending due to difficulties in obtaining samples.
SHOW YOUR WORK